In conclusion, as a rare subtype of AML, ABL is diagnosed with difficulty and associated with unique therapeutic complications, including anaphylaxis, and gastroduodenal and cutaneous involvement. The gene discussed is ABL1; the disease is acute myeloid leukemia.